Cargando…
Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines
Human T-cell Leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other inflammatory diseases. High viral DNA burden (VL) in peripheral blood mononuclear cells is a documented risk factor for ATLL and HAM...
Autores principales: | Pise-Masison, Cynthia A., Franchini, Genoveffa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609126/ https://www.ncbi.nlm.nih.gov/pubmed/36298639 http://dx.doi.org/10.3390/v14102084 |
Ejemplares similares
-
HTLV-1 burden dependent on hijacking monocytes chemotaxis
por: Castro-Amarante, Maria F, et al.
Publicado: (2015) -
Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
por: Omsland, Maria, et al.
Publicado: (2018) -
p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
por: Moles, Ramona, et al.
Publicado: (2019) -
Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide
por: Gutowska, Anna, et al.
Publicado: (2022) -
Role of regulatory proteins in HIV-1/HTLV-1 coinfection
por: Edwards, Dustin, et al.
Publicado: (2014)